Treatment and outcome of children and adolescents with N-methyl-d-aspartate receptor encephalitis
Αναστασία Ζεκερίδου(Mayo Clinic), Jérôme Honnorat(Université Claude Bernard Lyon 1), Géraldine Picard(Hospices Civils de Lyon), Frédéric Villega, Kumaran Deiva(Sorbonne Université), François Ducray(Centre National pour la Recherche Scientifique et Technique (CNRST)), Véronique Rogemond(Hospices Civils de Lyon), Jean‐Christophe Antoine(Centre Hospitalier Universitaire de Saint-Étienne), Cyril Gitiaux(Hôpital Necker-Enfants Malades), Marc Tardieu(Assistance Publique – Hôpitaux de Paris), Evgenia Karantoni(Institut du Cerveau), E. Mathias(Inserm), Jean‐Yves Delattre(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Aurélien Viaccoz(Centre National de la Recherche Scientifique)
Cited by 120
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
|Neurology Neuroimmunology & Neuroinflammation|2021|702
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|The Lancet Neurology|2021|518
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter
|Neuro-Oncology|2022|508
Continuous growth of mean tumor diameter in a subset of grade II gliomas
|Annals of Neurology|2003|485